• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Cytori Therapeutics, Inc. (CYTX)

    -NasdaqGM
    1.12 Down 0.01(0.88%) Feb 27, 4:00PM EST
    |After Hours : 1.11 Down 0.01 (0.89%) Feb 27, 7:59PM EST
    Add to Portfolio
    Prev Close:1.13
    Open:1.35
    Bid:N/A
    Ask:1.22 x 3500
    1y Target Est:5.67
    Beta:4.17
    Earnings Date:Mar 9 - Mar 13 (Est.)
    Day's Range:1.08 - 1.42
    52wk Range:0.36 - 3.33
    Volume:35,132,649
    Avg Vol (3m):3,078,360
    Market Cap:103.54M
    P/E (ttm):N/A
    EPS (ttm):-0.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTX

    Comparison

    Symbol% ChgMkt Cap
    CYTXDown 0.88%103.54M
    ASTM 0.00%N/A
    BAXUp 0.70%37.52B
    OSIRDown 0.40%592.71M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.33
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.45
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback